Semaglutide
-
healthSemaglutide Cuts Heavy Drinking in Alcohol Disorder Trial
A new trial shows semaglutide reduced heavy drinking in patients with alcohol use disorder and obesity, suggesting a new use for GLP-1 drugs.
-
healthSemaglutide Shows Promise in Boosting Motivation for Depression Patients
Study finds GLP-1 drug improves effort-based decision-making in major depressive disorder, opening new treatment avenues.
-
healthHealth Canada Approves Second Generic Semaglutide from Apotex
Health Canada clears Apotex's generic semaglutide for type 2 diabetes, expanding access to alternatives for brand-name drugs like Ozempic.
-
healthFDA Targets Copycat Weight-Loss Drugs, Limits Bulk Production
The FDA proposes removing Novo Nordisk and Eli Lilly's weight-loss drugs from a compounding list to curb unauthorized bulk production.
-
healthIndia's Generic Drugmakers Disrupt Weight Loss Market with Cheaper Semaglutide
Indian pharma companies launch generic semaglutide, slashing costs up to 70% and aiming to supply the global market.
-
healthCanada Approves First Generic Semaglutide, Paving Way for Lower Costs
Health Canada greenlights the first generic semaglutide, akin to Ozempic, potentially slashing treatment costs for millions of Canadians.
-
healthHealth Canada Approves First Generic Ozempic Amid Cost Concerns
Health Canada has approved the first generic version of Ozempic, a move expected to significantly reduce costs for Type 2 diabetes patients and potentially for weight loss treatments.
-
healthDoctor Flags 5 Common Pitfalls With Weight-Loss Drugs
A physician outlines critical mistakes patients make when using GLP-1 medications, emphasizing lifestyle changes, medical oversight, and proper nutrition for optimal results.